GRI Bio, Inc. (GRI)
Data as of , from SEC Form 4 filings.
See up to 3 months of GRI. The 7-day demo opens the 1M and 3M ranges and puts GRI on your watchlist.
Start 7-day demoLatest GRI insider trades
About GRI Bio, Inc. (GRI)
The SEC lists GRI Bio, Inc. under CIK 0001824293, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 8 December 2025. No offering has priced.
GRI Form 4 activity by transaction type, last 90 days
No Form 4 activity for GRI in the last 90 days.
GRI insider transactions (Form 4)
1818 Form 4 filings on record, the earliest from Aug 13, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Walter Marc Hertz - Officer | Grant or award | Stock Option (Right to Buy) | 103,067 | $0.00 | - | |
| Vipin Chaturvedi - Officer | Grant or award | Stock Option (Right to Buy) | 43,222 | $0.00 | - | |
| David Charles Baker - Director | Grant or award | Stock Option (Right to Buy) | 23,605 | $0.00 | - | |
| Camilla V. Simpson - Director | Grant or award | Stock Option (Right to Buy) | 23,605 | $0.00 | - | |
| Roelof Rongen - Director | Grant or award | Stock Option (Right to Buy) | 23,605 | $0.00 | - | |
| David Leslie Szekeres - Director | Grant or award | Stock Option (Right to Buy) | 39,897 | $0.00 | - | |
 Leanne Kelly - Officer | Grant or award | Stock Option (Right to Buy) | 43,222 | $0.00 | - | |
| David Charles Baker - Director | Grant or award | Stock Option (Right to Buy) | 5,994 | $0.00 | - | |
| Walter Marc Hertz - Officer | Grant or award | Stock Option (Right to Buy) | 26,688 | $0.00 | - | |
| Vipin Chaturvedi - Officer | Grant or award | Stock Option (Right to Buy) | 11,854 | $0.00 | - | |
| Camilla V. Simpson - Director | Grant or award | Stock Option (Right to Buy) | 5,994 | $0.00 | - | |
| Roelof Rongen - Director | Grant or award | Stock Option (Right to Buy) | 5,994 | $0.00 | - | |
| David Leslie Szekeres - Director | Grant or award | Stock Option (Right to Buy) | 10,276 | $0.00 | - | |
| Leanne Kelly - Officer | Grant or award | Stock Option (Right to Buy) | 11,854 | $0.00 | - | |
| David Charles Baker - Director | Grant or award | Stock Option (Right to Buy) | 4,527 | $0.00 | - | |
| Camilla V. Simpson - Director | Grant or award | Stock Option (Right to Buy) | 4,527 | $0.00 | - | |
| Roelof Rongen - Director | Grant or award | Stock Option (Right to Buy) | 4,527 | $0.00 | - | |
| David Leslie Szekeres - Director | Grant or award | Stock Option (Right to Buy) | 7,545 | $0.00 | - |
GRI insider trading FAQ
What is the latest insider trade for GRI?
GRI Bio, Inc. (GRI) has filed no insider reports in the last 90 days. The most recent on record is dated 18 September 2025. The full record for GRI runs to 18 Form 4 filings, the earliest from 13 August 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GRI stock?
No insider purchases of GRI were filed in the last 90 days.
How many insiders are selling GRI stock?
No insider sales of GRI were filed in the last 90 days.
Where can I see GRI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GRI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Walter Marc Hertz view on EDGAR
- - Vipin Chaturvedi view on EDGAR
- - David Charles Baker view on EDGAR
- - Camilla V. Simpson view on EDGAR
- - Roelof Rongen view on EDGAR
- - David Leslie Szekeres view on EDGAR
- - Leanne Kelly view on EDGAR
- - David Charles Baker view on EDGAR
- - Walter Marc Hertz view on EDGAR
- - Vipin Chaturvedi view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where GRI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GRI with a 7-day demo
- GRI on your watchlist
- Every GRI Form 4 filing on record
- Up to 3 months of GRI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
